步長製藥(603858.SH):陝西步長擬對經營範圍進行變更
格隆匯 12 月 24日丨步長製藥(603858.SH)公佈,公司於2020年12月23日召開了第三屆董事會第三十七次會議,審議通過了《關於全資子公司經營範圍變更的議案》,全資子公司陝西步長製藥有限公司(“陝西步長”)因業務發展需要,擬對經營範圍進行變更。
變更前:開發、生產腦心通及中風健腦帽系列產品;膠囊劑、片劑、顆粒劑、合劑、糖漿劑、中藥前處理、中藥提取。銷售自產產品。中藥材的種植、銷售(僅限於本企業種植產品。國家限制類除外);中藥材技術的研究與技術轉讓。技術服務,來料加工。(依法須經批准的項目,經相關部門批准後方可開展經營活動)
變更後:一般項目:技術服務、技術開發、技術諮詢、技術交流、技術轉讓、技術推廣;中草藥種植。(除依法須經批准的項目外,憑營業執照依法自主開展經營活動)。
許可項目:藥品生產;藥品批發;藥品委託生產。(依法須經批准的項目,經相關部門批准後方可開展經營活動,具體經營項目以審批結果為準)。
陝西步長的主要產品為腦心通膠囊,此次經營範圍變更後陝西步長的主營業務、主要產品不會發生變化。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.